IP Library Granted Patent US 12,558,523
Granted Patent B2
US 12,558,523 · App. 18/302,646 · Granted Feb 24, 2026

Devices for transvascular retrograde access placement

Inventor: Lakshmikumar Pillai (Morgantown, WV)
Assignee: Vascular Access Technologies, Inc.
A61M25/09041A61M25/09A61M39/0247A61M25/0068A61M25/0133A61M25/0136A61M2025/0681A61M2025/09116A61M2025/09125A61M2025/09175A61M2025/09183A61M2039/0258A61M2039/0273A61M2039/0282
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,558,523
App. No.
18/302,646
Granted
Feb 24, 2026
Kind
B2
Abstract

The present invention relates to methods of transvascular retrograde access placement and to devices that facilitate these methods. For purposes of the present invention, transvascular retrograde access placement generally comprises the insertion of a vascular catheter into a central blood vessel through the puncturing of the central blood vessel from the inside of the central blood vessel with a needle or other similarly configured device, or a needle-tipped guidewire of the present invention, and exiting that needle from the patient through the skin rather than the traditional approach of inserting a needle from the outside of the skin surface to the inside of a blood vessel.

Claims (36)

1 . A method of accessing a vessel of a patient from an outside of a patient by penetrating the vessel from inside the patient, the method comprising:

inserting a vascular catheter at a cannulation site into a peripheral vein of a patient over a guidewire, the vascular catheter comprising:

a catheter body comprising:

a first lumen for receiving the guidewire, the first lumen extending longitudinally through the catheter body from a proximal end of the catheter body to an opening at a distal portion of the vascular catheter, the distal portion extending at an angle from a longitudinal axis of the catheter body, the catheter body being configured to be inserted into a blood vessel over the guidewire within the first lumen; and

a second lumen for receiving a needle-tipped guidewire, the second lumen positioned exteriorly from the proximal end of the catheter body to the distal portion of the vascular catheter, a distal portion of the second lumen extending at an angle from the longitudinal axis of the catheter body to a distal opening, the distal opening of the second lumen facing a wall of the blood vessel when the catheter body has been inserted into the blood vessel;

advancing the vascular catheter from the peripheral vein of the patient to a central vein of the patient;

positioning the vascular catheter within the central vein such that a distal opening of the second lumen is directed to a desired exit site on the wall of the central vein;

advancing the needle-tipped guidewire through the second lumen; and

piercing the desired exit site on the wall of the central vein and skin of the patient at an exit site with the needle-tipped guidewire.

2 . The method of claim 1 , further comprising passing a secondary vascular catheter over the needle-tipped guidewire from the outside of the skin such that a first end of the secondary vascular catheter passes through the exit site into the second vessel and a second end of the secondary vascular catheter is exposed from the skin of the patient.

3 . The method of claim 2 , further comprising removing the needle-tipped guidewire from the patient while the secondary vascular catheter remains in place.

4 . The method of claim 3 , wherein the needle-tipped guidewire is removed at either the cannulation site or the exit site.

5 . The method of claim 2 , wherein the vascular catheter is removed from the patient.

6 . The method of claim 5 , wherein the vascular catheter is removed from the patient before the secondary vascular catheter is inserted into the central vein.

7 . The method of claim 1 , wherein the curve ranges between 45 to 90 degrees from an axis of a proximal portion of the vascular catheter.

8 . The method of claim 1 , wherein the peripheral vein is a femoral vein.

9 . The method of claim 8 , wherein the central vein is a jugular vein.

10 . The method of claim 8 , wherein the central vein is a subclavian vein.

11 . The method of claim 1 , wherein the peripheral vein is an antecubital vein.

12 . The method of claim 11 , wherein the central vein is a jugular vein.

13 . The method of claim 11 , wherein the central vein is a subclavian vein.

14 . The method of claim 1 , wherein the exit site is at a mid-neck area of the patient.

15 . The method of claim 1 , wherein positioning the vascular catheter within the second vessel includes rotating the vascular catheter such that the distal opening of the second lumen is directed to the desired exit site on the wall of the second vessel.

16 . The method of claim 1 , further comprising visualizing diagnostically-opaque markers the vascular catheter prior to passing the needle-tipped guidewire through the desired exit site.

17 . A method of accessing a vessel of a patient from an outside of a patient by penetrating the vessel from inside the patient, the method comprising:

inserting a vascular catheter at a cannulation site into a first vessel of a patient over a guidewire, the vascular catheter comprising:

a catheter body comprising:

a first lumen for receiving the guidewire, the first lumen extending longitudinally through the catheter body from a proximal end of the catheter body to an opening at a distal portion of the vascular catheter, the distal portion extending at an angle from a longitudinal axis of the catheter body, the catheter body being configured to be inserted into a blood vessel over the guidewire within the first lumen; and

a second lumen for receiving a needle-tipped guidewire, the second lumen positioned exteriorly from the proximal end of the catheter body to the distal portion of the vascular catheter, a distal portion of the second lumen extending at an angle from the longitudinal axis of the catheter body to a distal opening, the distal opening of the second lumen facing a wall of the blood vessel when the catheter body has been inserted into the blood vessel;

advancing the vascular catheter from the first vessel of the patient to a second vessel of the patient;

positioning the vascular catheter within the second vessel such that a distal opening of the second lumen is directed to a desired exit site on the wall of the second vessel;

advancing the needle-tipped guidewire through the second lumen;

piercing the desired exit site on the wall of the second vessel and skin of the patient at an exit site with the needle-tipped guidewire;

passing a secondary vascular catheter over the needle-tipped guidewire from the outside of the skin such that a first end of the secondary vascular catheter passes through the exit site into the central vein and a second end of the secondary vascular catheter is exposed from the skin of the patient; and

removing the vascular catheter and needle-tipped guidewire from the cannulation site while the secondary vascular catheter remains in place and utilizing the secondary vascular catheter as the sole access point to perform an interventional procedure.

18 . The method of claim 17 , wherein removing the vascular catheter and needle-tipped guidewire from the cannulation site while the secondary vascular catheter remains in place further comprising removing the vascular catheter and needle-tipped guidewire from the cannulation site such that the exit site becomes the sole access point to the central vein.

Assignments (3)
SECURITY INTEREST Recorded Jan 29, 2025
From: VASCULAR ACCESS TECHNOLOGIES, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 070049/0779 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: VASCULAR ACCESS TECHNOLOGIES, LLC
To: VASCULAR ACCESS TECHNOLOGIES, INC.
Reel/Frame 065783/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2023
From: PILLAI, LAKSHMIKUMAR
To: VASCULAR ACCESS TECHNOLOGIES, INC.
Reel/Frame 064338/0800 →
Continuity (5)
Continuation 16557641 · Aug 30, 2019
Continuation 15347478 · Nov 9, 2016
Division 11424131 · Jun 14, 2006
Continuation 11381229 · May 2, 2006
Related Publication 20230381463A1 · Nov 30, 2023
References Cited (161)
US 4559039A · Ash et al. · 1985 [cited by applicant]
US 4790825A · Bernstein et al. · 1988 [cited by applicant]
US 4966163A · Kraus et al. · 1990 [cited by applicant]
US 5040540A · Sackner · 1991 [cited by examiner]
US 5295493A · Radisch, Jr. · 1994 [cited by applicant]
US 5389090A · Fischell et al. · 1995 [cited by applicant]
US 5421348A · Larnard · 1995 [cited by applicant]
US 5492530A · Fischell et al. · 1996 [cited by applicant]
US 5591195A · Taheri · 1997 [cited by examiner]
US 5685820A · Riek et al. · 1997 [cited by applicant]
US 5733248A · Adams et al. · 1998 [cited by applicant]
US 6047700A · Eggers et al. · 2000 [cited by applicant]
US 6068638A · Makower · 2000 [cited by examiner]
US 6102926A · Tartaglia et al. · 2000 [cited by applicant]
US 6190353B1 · Makower · 2001 [cited by examiner]
US 6217527B1 · Selmon · 2001 [cited by examiner]
US 6379319B1 · Garibotto · 2002 [cited by examiner]
US 6475226B1 · Belef et al. · 2002 [cited by applicant]
US 6485513B1 · Fan · 2002 [cited by applicant]
US 6508777B1 · Macoviak et al. · 2003 [cited by applicant]
US 6554792B2 · Hughes · 2003 [cited by applicant]
US 6554794B1 · Mueller et al. · 2003 [cited by applicant]
US 6623480B1 · Kuo et al. · 2003 [cited by applicant]
US 6709444B1 · Makower · 2004 [cited by applicant]
US 6726677B1 · Flaherty et al. · 2004 [cited by applicant]
US 6929633B2 · Evans et al. · 2005 [cited by applicant]
US 6955657B1 · Webler · 2005 [cited by applicant]
US 7008979B2 · Schottman et al. · 2006 [cited by applicant]
US 7344567B2 · Slemker · 2008 [cited by applicant]
US 7374567B2 · Heuser · 2008 [cited by applicant]
US 7648517B2 · Makower · 2010 [cited by examiner]
US 7688517B2 · Omura et al. · 2010 [cited by applicant]
US 8019420B2 · Hine et al. · 2011 [cited by applicant]
US 8241311B2 · Ward et al. · 2012 [cited by applicant]
US 8374680B2 · Thompson · 2013 [cited by applicant]
US 8409236B2 · Pillai · 2013 [cited by applicant]
US 8568435B2 · Pillai et al. · 2013 [cited by applicant]
US 9220874B2 · Pillai et al. · 2015 [cited by applicant]
US 9282967B2 · Paris et al. · 2016 [cited by applicant]
US 9511214B2 · Pillai · 2016 [cited by examiner]
US 9623217B2 · Pillai · 2017 [cited by applicant]
US 11654266B2 · Pillai · 2023 [cited by examiner]
US 20010010006A1 · Bachinski et al. · 2001 [cited by applicant]
US 20010012924A1 · Milo et al. · 2001 [cited by applicant]
US 20010023346A1 · Loeb · 2001 [cited by applicant]
US 20010034547A1 · Hall et al. · 2001 [cited by applicant]
US 20020004666A1 · Schwager et al. · 2002 [cited by applicant]
US 20020029060A1 · Hogendijk et al. · 2002 [cited by applicant]
US 20020120250A1 · Altman · 2002 [cited by applicant]
US 20020122877A1 · Harish et al. · 2002 [cited by applicant]
US 20020133168A1 · Smedley et al. · 2002 [cited by applicant]
US 20020169377A1 · Khairkhahan et al. · 2002 [cited by applicant]
US 20030040771A1 · Hyodoh · 2003 [cited by applicant]
US 20030078519A1 · Salahieh · 2003 [cited by examiner]
US 20040039371A1 · Tockman et al. · 2004 [cited by applicant]
US 20040059280A1 · Makower et al. · 2004 [cited by applicant]
US 20040082850A1 · Bonner et al. · 2004 [cited by applicant]
US 20040097880A1 · Schur · 2004 [cited by applicant]
US 20040116878A1 · Byrd et al. · 2004 [cited by applicant]
US 20040133168A1 · Salcudean et al. · 2004 [cited by applicant]
US 20040181150A1 · Evans et al. · 2004 [cited by applicant]
US 20040181238A1 · Zarbatany et al. · 2004 [cited by applicant]
US 20050101984A1 · Chanduszko et al. · 2005 [cited by applicant]
US 20050149094A1 · Kasahara et al. · 2005 [cited by applicant]
US 20050149097A1 · Regnell et al. · 2005 [cited by applicant]
US 20050209579A1 · Yacoubian et al. · 2005 [cited by applicant]
US 20050279370A1 · Aboul-Hosn et al. · 2005 [cited by applicant]
US 20060009737A1 · Whiting et al. · 2006 [cited by applicant]
US 20060135962A1 · Kick et al. · 2006 [cited by applicant]
US 20060173440A1 · Lamson · 2006 [cited by applicant]
US 20060189929A1 · Lary · 2006 [cited by examiner]
US 20060247750A1 · Seifert et al. · 2006 [cited by applicant]
US 20070021767A1 · Breznock · 2007 [cited by applicant]
US 20070203515A1 · Heuser et al. · 2007 [cited by applicant]
US 20080082136A1 · Gaudini · 2008 [cited by applicant]
US 20080125748A1 · Patel · 2008 [cited by applicant]
US 20080154172A1 · Mauch · 2008 [cited by applicant]
US 20080171944A1 · Brenneman et al. · 2008 [cited by applicant]
US 20080215008A1 · Nance et al. · 2008 [cited by applicant]
US 20080228171A1 · Kugler et al. · 2008 [cited by applicant]
US 20080249565A1 · Michler et al. · 2008 [cited by applicant]
US 20090024072A1 · Criado et al. · 2009 [cited by applicant]
US 20090112050A1 · Farnan et al. · 2009 [cited by applicant]
US 20090240122A1 · Avitsian · 2009 [cited by applicant]
US 20100185216A1 · Garrison et al. · 2010 [cited by applicant]
US 20100249491A1 · Farnan et al. · 2010 [cited by applicant]
US 20110178530A1 · Bly · 2011 [cited by applicant]
US 20110190871A1 · Trollsas et al. · 2011 [cited by applicant]
US 20110295206A1 · Gurley · 2011 [cited by applicant]
US 20120130468A1 · Khosravi et al. · 2012 [cited by applicant]
US 20120136247A1 · Pillai · 2012 [cited by applicant]
US 20120136366A1 · Pillai · 2012 [cited by applicant]
US 20120290075A1 · Mortisen et al. · 2012 [cited by applicant]
US 20130006282A1 · Wilkinson · 2013 [cited by applicant]
US 20130072957A1 · Anderson · 2013 [cited by applicant]
US 20130324901A1 · Pillai · 2013 [cited by applicant]
US 20130324967A1 · Pillai et al. · 2013 [cited by applicant]
US 20140018837A1 · Zhou et al. · 2014 [cited by applicant]
US 20140025161A1 · Stankus et al. · 2014 [cited by applicant]
US 20140046346A1 · Hentges et al. · 2014 [cited by applicant]
US 20140107642A1 · Rios et al. · 2014 [cited by applicant]
US 20140124418A1 · Ishihara · 2014 [cited by applicant]
US 20140142418A1 · Gurley et al. · 2014 [cited by applicant]
US 20140142677A1 · Heuser et al. · 2014 [cited by applicant]
US 20140288634A1 · Shalev · 2014 [cited by applicant]
US 20150320357A1 · Kauaguntla et al. · 2015 [cited by applicant]
US 20160120673A1 · Siegel et al. · 2016 [cited by applicant]
US 20160172922A1 · Kamiya · 2016 [cited by applicant]
US 20170035591A1 · De Pablo et al. · 2017 [cited by applicant]
US 20170056625A1 · Pillai · 2017 [cited by applicant]
US 20170296798A1 · Kume et al. · 2017 [cited by applicant]
US 20180161551A1 · Pillai · 2018 [cited by applicant]
US 20190321600A1 · Pillai · 2019 [cited by applicant]
US 20200069919A1 · Pillai · 2020 [cited by applicant]
US 20200338320A1 · Pillai · 2020 [cited by applicant]
US 20220401704A1 · Pillai · 2022 [cited by applicant]
US 20230218869A1 · Pillai · 2023 [cited by applicant]
US 20230381395A1 · Pillai · 2023 [cited by applicant]
WO 2004018029 · 2004 [cited by applicant]
WO 2005053547 · 2005 [cited by applicant]
WO 2011068540 · 2011 [cited by applicant]
WO 2013119547 · 2013 [cited by applicant]
Welch et al. Primary Varicose Veins of the Upper Extremity: A Report of Three Cases. The Journal of Vascular Surgery. Nov. 1994, p. 839-843 (Year: 1994). [cited by examiner]
Office Action dated Nov. 6, 2023 for U.S. Appl. No. 17/810,529. [cited by applicant]
Office Action dated Feb. 12, 2024 for U.S. Appl. No. 17/810,529. [cited by applicant]
Notice of Allowance dated Jan. 27, 2023 for U.S. Appl. No. 16/557,641. [cited by applicant]
Notice of Allowance dated Jan. 27, 2023 for U.S. Appl. No. 15/855,672. [cited by applicant]
Notice of Allowance dated Jan. 28, 2019 for U.S. Appl. No. 14/949,243. [cited by applicant]
Notice of Allowance dated Feb. 5, 2020 for U.S. Appl. No. 15/835,114. [cited by applicant]
Notice of Allowance dated Mar. 19, 2019 for U.S. Appl. No. 15/464,055. [cited by applicant]
Notice of Allowance dated May 1, 2019 for U.S. Appl. No. 15/347,478. [cited by applicant]
Notice of Allowance dated Oct. 26, 2022 for U.S. Appl. No. 16/847,281. [cited by applicant]
Office Action dated Feb. 2, 2021 for U.S. Appl. No. 15/855,672. [cited by applicant]
Office Action dated Jan. 30, 2018 for U.S. Appl. No. 14/949,243. [cited by applicant]
Office Action dated Feb. 3, 2021 for U.S. Appl. No. 15/834,998. [cited by applicant]
Office Action dated Apr. 13, 2020 for U.S. Appl. No. 15/834,998. [cited by applicant]
Office Action dated Apr. 13, 2022 for U.S. Appl. No. 15/855,672. [cited by applicant]
Office Action dated May 10, 2022 for U.S. Appl. No. 16/847,281. [cited by applicant]
Office Action dated May 25, 2021 for U.S. Appl. No. 15/834,998. [cited by applicant]
Office Action dated May 30, 2017 for U.S. Appl. No. 14/949,243. [cited by applicant]
Office Action dated Jun. 14, 2018 for U.S. Appl. No. 14/949,243. [cited by applicant]
Office Action dated Jun. 22, 2021 for U.S. Appl. No. 15/855,672. [cited by applicant]
Office Action dated Aug. 11, 2022 for U.S. Appl. No. 16/557,641. [cited by applicant]
Office Action dated Aug. 29, 2019 for U.S. Appl. No. 15/835,114. [cited by applicant]
Office Action dated Sep. 7, 2018 for U.S. Appl. No. 15/347,478. [cited by applicant]
Office Action dated Sep. 14, 2022 for U.S. Appl. No. 15/855,672. [cited by applicant]
Office Action dated Sep. 24, 2020 for U.S. Appl. No. 15/834,998. [cited by applicant]
Office Action dated Sep. 27, 2018 for U.S. Appl. No. 15/464,055. [cited by applicant]
Office Action dated Oct. 1, 2021 for U.S. Appl. No. 15/855,672. [cited by applicant]
Office Action dated Oct. 2, 2018 for U.S. Appl. No. 14/949,243. [cited by applicant]
Office Action dated Oct. 23, 2019 for U.S. Appl. No. 15/834,998. [cited by applicant]
Faul , et al., Vascular Disease Management, vol. 5 No. 5, 128-133. [cited by applicant]
Huang , et al., “Evaluation of the Needle Technique for Producing an Arteriovenous Fistula”, Journal of Applied Physiology, vol. 77(6), Dec. 1, 1994, 2907-2911. [cited by applicant]
Khanna , et al., “Sharpening of Hollow Silicon Microneedles to Reduce Skin Penetration Force”, Mar. 15, 2010, 045011. [cited by applicant]
Lumend Inc. , “Outback LTD Re-Entry Catheter; Product Resources (http://www.lumend.com/Images/Technology/Products/brochure.pdf)”, Jul. 19, 2006. [cited by applicant]
Mewissen , “Revascularization of Long FP Arterial Occlusions”, Endovascular Today, Mar. 1, 2004, 2-4. [cited by applicant]
O'Callaghan , et al., “Dynamics of Stab Wounds: Force Required for Penetration of Various Cadaveric Himan Tissues”, Forensic Sci. Int'l., vol. 104, Oct. 11, 1999, 173-178. [cited by applicant]
Office Action dated Feb. 22, 2022 for U.S. Appl. No. 15/834,998. [cited by applicant]
Office Action dated Sep. 30, 2021 for U.S. Appl. No. 16/503,983. [cited by applicant]
Office Action dated Jun. 17, 2024 for U.S. Appl. No. 18/065,450. [cited by applicant]
Office Action dated Sep. 5, 2025 for U.S. Appl. No. 18/301,931. [cited by applicant]